WASHINGTON — Republicans on Capitol Hill are attempting to use a bill to address the opioid crisis to deliver a major victory for the pharmaceutical industry, reversing a measure that put drug makers on the hook for a higher share of Medicare drug costs, according to congressional staff and lobbyists.

The effort could also result in passage of the CREATES Act, legislation that would facilitate the entry of lower-priced generic and biosimilar drugs to the market.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • They are really too corrupt to even consider how their greed and apathy cause this so called epidemic in the first place. Even the number of American deaths, has no impact on their unbridled greed. The addiction crisis should have been addressed by the A.C.A, but these industry puppets, took out key provisions, to undermine our healthcare. They have no shame!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy